Eric A. Toth

2.0k total citations
53 papers, 1.5k citations indexed

About

Eric A. Toth is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Eric A. Toth has authored 53 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 11 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Epidemiology. Recurrent topics in Eric A. Toth's work include Monoclonal and Polyclonal Antibodies Research (11 papers), DNA Repair Mechanisms (8 papers) and S100 Proteins and Annexins (8 papers). Eric A. Toth is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), DNA Repair Mechanisms (8 papers) and S100 Proteins and Annexins (8 papers). Eric A. Toth collaborates with scholars based in United States, Nepal and United Kingdom. Eric A. Toth's co-authors include Gerald M. Wilson, Todd O. Yeates, Edwin Pozharski, Phuong Pham, Laura Silvian, Jeff D. Ballin, Myron F. Goodman, David J. Weber, Tom Ellenberger and M.R. Sawaya and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Eric A. Toth

50 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric A. Toth United States 23 1.2k 170 145 119 110 53 1.5k
Wolfgang Knecht Sweden 28 1.5k 1.3× 204 1.2× 135 0.9× 191 1.6× 348 3.2× 83 2.1k
Darrell R. Davis United States 23 1.8k 1.6× 134 0.8× 109 0.8× 70 0.6× 125 1.1× 49 2.2k
Stephen A. Margosiak United States 21 925 0.8× 194 1.1× 106 0.7× 83 0.7× 133 1.2× 28 1.6k
Diana Wetmore United States 14 684 0.6× 126 0.7× 129 0.9× 30 0.3× 141 1.3× 20 1.2k
Ivan Zlatev United States 21 1.3k 1.1× 166 1.0× 69 0.5× 43 0.4× 178 1.6× 46 1.7k
Jinming Zhou China 24 846 0.7× 213 1.3× 173 1.2× 80 0.7× 354 3.2× 110 1.9k
Huanyu Tao China 12 995 0.8× 86 0.5× 88 0.6× 85 0.7× 246 2.2× 21 1.5k
Miljan Simonović United States 24 1.0k 0.9× 75 0.4× 171 1.2× 72 0.6× 59 0.5× 41 1.5k
P.J. Finerty Canada 15 1.1k 0.9× 105 0.6× 87 0.6× 145 1.2× 52 0.5× 16 1.5k
Paul Rogers United Kingdom 17 787 0.7× 101 0.6× 85 0.6× 76 0.6× 291 2.6× 32 1.4k

Countries citing papers authored by Eric A. Toth

Since Specialization
Citations

This map shows the geographic impact of Eric A. Toth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Toth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Toth more than expected).

Fields of papers citing papers by Eric A. Toth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric A. Toth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Toth. The network helps show where Eric A. Toth may publish in the future.

Co-authorship network of co-authors of Eric A. Toth

This figure shows the co-authorship network connecting the top 25 collaborators of Eric A. Toth. A scholar is included among the top collaborators of Eric A. Toth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric A. Toth. Eric A. Toth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rocamora, Frances, et al.. (2023). Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies. Biotechnology Advances. 67. 108206–108206. 24 indexed citations
3.
Yin, Rui, Ruixue Wang, Johnathan D. Guest, et al.. (2023). Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies. Nature Communications. 14(1). 3980–3980. 13 indexed citations
4.
Li, Xiaofeng, et al.. (2023). Site-directed neutralizing antibodies targeting structural sites on SARS-CoV-2 spike protein. New Biotechnology. 80. 27–36. 2 indexed citations
5.
Toth, Eric A., Alexander K. Andrianov, & Thomas R. Fuerst. (2023). Prospects for developing an Hepatitis C virus E1E2‐based nanoparticle vaccine. Reviews in Medical Virology. 33(5). e2474–e2474. 8 indexed citations
6.
Pierce, Brian G., Zhen–Yong Keck, Ruixue Wang, et al.. (2020). Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-Neutralization. Journal of Virology. 94(22). 24 indexed citations
7.
Toth, Eric A., et al.. (2016). Crystallization of Lysozyme on Metal Surfaces Using a Monomode Microwave System. Nano Biomedicine and Engineering. 8(2). 7 indexed citations
8.
Kerr, Candace L., Henryk Szmacinski, Matthew Fisher, et al.. (2016). Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival. Oncogene. 36(21). 2981–2990. 53 indexed citations
9.
Pozharski, Edwin, et al.. (2016). A direct interaction between NQO1 and a chemotherapeutic dimeric naphthoquinone. BMC Structural Biology. 16(1). 1–1. 22 indexed citations
10.
Lanning, Maryanna E., Wenbo Yu, Jeremy L. Yap, et al.. (2016). Structure-based design of N-substituted 1-hydroxy-4-sulfamoyl-2-naphthoates as selective inhibitors of the Mcl-1 oncoprotein. European Journal of Medicinal Chemistry. 113. 273–292. 43 indexed citations
11.
Jin, Jin, et al.. (2014). Interaction of apurinic/apyrimidinic endonuclease 2 (Apn2) with Myh1 DNA glycosylase in fission yeast. DNA repair. 15. 1–10. 6 indexed citations
12.
Pazgier, Marzena, Bryan Ericksen, Minhua Ling, et al.. (2013). Structural and Functional Analysis of the Pro-Domain of Human Cathelicidin, LL-37. Biochemistry. 52(9). 1547–1558. 36 indexed citations
13.
Maiti, Atanu, et al.. (2012). Crystal Structure of Human Methyl-Binding Domain IV Glycosylase Bound to Abasic DNA. Journal of Molecular Biology. 420(3). 164–175. 32 indexed citations
14.
McKnight, Laura E., E. Prabhu Raman, Paul T. Wilder, et al.. (2012). Structure-Based Discovery of a Novel Pentamidine-Related Inhibitor of the Calcium-Binding Protein S100B. ACS Medicinal Chemistry Letters. 3(12). 975–979. 20 indexed citations
15.
Zucconi, Beth E., Jeff D. Ballin, Brandy Y. Brewer, et al.. (2010). Alternatively Expressed Domains of AU-rich Element RNA-binding Protein 1 (AUF1) Regulate RNA-binding Affinity, RNA-induced Protein Oligomerization, and the Local Conformation of Bound RNA Ligands. Journal of Biological Chemistry. 285(50). 39127–39139. 51 indexed citations
16.
Charpentier, Thomas H., Laura E. Thompson, Melissa A. Liriano, et al.. (2010). The Effects of CapZ Peptide (TRTK-12) Binding to S100B–Ca2+ as Examined by NMR and X-ray Crystallography. Journal of Molecular Biology. 396(5). 1227–1243. 44 indexed citations
17.
Charpentier, Thomas H., Paul T. Wilder, Kristen M. Varney, Eric A. Toth, & David J. Weber. (2006). Neem-seed oil inhibits the growth of breast cancer cells. Cancer Research. 66. 456–456. 3 indexed citations
18.
Silvian, Laura, et al.. (2001). Crystal structure of a DinB family error-prone DNA polymerase from Sulfolobus solfataricus.. Nature Structural Biology. 8(11). 984–989. 144 indexed citations
19.
20.
Toth, Eric A. & Todd O. Yeates. (2000). The structure of adenylosuccinate lyase, an enzyme with dual activity in the de novo purine biosynthetic pathway. Structure. 8(2). 163–174. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wolfgang Knecht Breakdown of academic impact, for papers by Darrell R. Davis Breakdown of academic impact, for papers by Stephen A. Margosiak Breakdown of academic impact, for papers by Diana Wetmore Breakdown of academic impact, for papers by Ivan Zlatev Breakdown of academic impact, for papers by Jinming Zhou Breakdown of academic impact, for papers by Huanyu Tao Breakdown of academic impact, for papers by Miljan Simonović Breakdown of academic impact, for papers by P.J. Finerty Breakdown of academic impact, for papers by Paul Rogers
Rankless by CCL
2026